Pacer Advisors, Inc. Gilead Sciences, Inc. Transaction History

Pacer Advisors, Inc.

  • $33.6 Billion
  • Q3 2025

A detailed history of Pacer Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 3,590,745 shares of GILD stock, worth $425 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
3,590,745
Previous 4,119,722 12.84%
Holding current value
$425 Million
Previous $457 Million 12.74%
% of portfolio
1.19%
Previous 1.33%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025
SELL
$108.22 - $120.47 $57.2 Million - $63.7 Million
-528,977 Reduced 12.84%
3,590,745 $399 Million
Q2 2025

Aug 12, 2025
SELL
$96.91 - $113.0 $74.2 Million - $86.5 Million
-765,414 Reduced 15.67%
4,119,722 $457 Million
Q1 2025

May 06, 2025
SELL
$89.14 - $117.41 $138 Million - $182 Million
-1,549,529 Reduced 24.08%
4,885,136 $547 Million
Q4 2024

Jan 22, 2025
BUY
$83.95 - $97.9 $475 Million - $553 Million
5,653,075 Added 723.28%
6,434,665 $594 Million
Q3 2024

Nov 12, 2024
SELL
$66.59 - $83.99 $473 Million - $597 Million
-7,108,073 Reduced 90.09%
781,590 $65.5 Million
Q2 2024

Aug 13, 2024
BUY
$63.15 - $72.88 $98.8 Million - $114 Million
1,564,792 Added 24.74%
7,889,663 $541 Million
Q1 2024

May 10, 2024
BUY
$71.58 - $87.29 $91.5 Million - $112 Million
1,278,219 Added 25.33%
6,324,871 $463 Million
Q4 2023

Jan 16, 2024
BUY
$73.27 - $83.09 $36.2 Million - $41 Million
493,920 Added 10.85%
5,046,652 $409 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $61.5 Million - $67 Million
831,107 Added 22.33%
4,552,732 $341 Million
Q2 2023

Jul 12, 2023
BUY
$76.01 - $86.7 $17.3 Million - $19.8 Million
228,183 Added 6.53%
3,721,625 $287 Million
Q1 2023

May 02, 2023
BUY
$77.31 - $88.08 $67.1 Million - $76.4 Million
867,597 Added 33.04%
3,493,442 $290 Million
Q4 2022

Feb 06, 2023
SELL
$62.32 - $89.47 $949,195 - $1.36 Million
-15,231 Reduced 0.58%
2,625,845 $225 Million
Q3 2022

Oct 18, 2022
BUY
$59.54 - $68.01 $6.84 Million - $7.82 Million
114,944 Added 4.55%
2,641,076 $163 Million
Q2 2022

Aug 12, 2022
BUY
$57.72 - $65.01 $69 Million - $77.7 Million
1,195,509 Added 89.85%
2,526,132 $156 Million
Q1 2022

Apr 05, 2022
BUY
$57.92 - $72.58 $48.5 Million - $60.7 Million
836,884 Added 169.5%
1,330,623 $79.1 Million
Q4 2021

Feb 03, 2022
BUY
$64.88 - $73.64 $4.82 Million - $5.47 Million
74,236 Added 17.7%
493,739 $35.9 Million
Q3 2021

Oct 15, 2021
BUY
$67.69 - $73.03 $3.52 Million - $3.8 Million
52,013 Added 14.15%
419,503 $29.3 Million
Q2 2021

Jul 21, 2021
BUY
$63.47 - $69.35 $7.38 Million - $8.07 Million
116,320 Added 46.31%
367,490 $25.3 Million
Q1 2021

Apr 05, 2021
BUY
$60.0 - $68.46 $138,960 - $158,553
2,316 Added 0.93%
251,170 $16.2 Million
Q4 2020

Jan 20, 2021
SELL
$56.65 - $64.55 $350,833 - $399,758
-6,193 Reduced 2.43%
248,854 $14.5 Million
Q3 2020

Oct 19, 2020
SELL
$62.1 - $78.08 $910,448 - $1.14 Million
-14,661 Reduced 5.44%
255,047 $16.1 Million
Q2 2020

Jul 29, 2020
BUY
$72.34 - $84.0 $4.54 Million - $5.27 Million
62,776 Added 30.34%
269,708 $20.8 Million
Q1 2020

Apr 23, 2020
BUY
$62.63 - $80.22 $6.72 Million - $8.61 Million
107,270 Added 107.63%
206,932 $17.4 Million
Q4 2019

Feb 10, 2020
SELL
$61.62 - $67.78 $12.3 Million - $13.5 Million
-199,684 Reduced 66.71%
99,662 $6.48 Million
Q3 2019

Oct 10, 2019
BUY
$62.51 - $69.0 $1.13 Million - $1.24 Million
18,031 Added 6.41%
299,346 $19 Million
Q2 2019

Aug 12, 2019
BUY
$61.87 - $69.38 $1.28 Million - $1.44 Million
20,767 Added 7.97%
281,315 $19 Million
Q1 2019

Apr 10, 2019
BUY
$62.53 - $70.05 $13.1 Million - $14.7 Million
210,220 Added 417.7%
260,548 $16.9 Million
Q4 2018

Feb 13, 2019
SELL
$60.54 - $79.0 $10.3 Million - $13.4 Million
-169,864 Reduced 77.14%
50,328 $3.15 Million
Q3 2018

Nov 14, 2018
BUY
$71.28 - $78.92 $3.79 Million - $4.2 Million
53,165 Added 31.83%
220,192 $17 Million
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $1.98 Million - $2.3 Million
30,447 Added 22.29%
167,027 $11.8 Million
Q1 2018

May 14, 2018
BUY
$72.84 - $88.8 $2.07 Million - $2.53 Million
28,476 Added 26.34%
136,580 $10.3 Million
Q4 2017

Feb 14, 2018
BUY
$71.15 - $83.52 $1.67 Million - $1.95 Million
23,402 Added 27.63%
108,104 $7.75 Million
Q3 2017

Nov 08, 2017
BUY
$72.11 - $85.47 $6.11 Million - $7.24 Million
84,702
84,702 $6.86 Million

Others Institutions Holding GILD

# of Institutions
2,329
Shares Held
1.03B
Call Options Held
12.1M
Put Options Held
9.13M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $148B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email